Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

154.07 +7.66 (+5.24%)
Streaming Delayed Price Updated: 11:16 AM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? ↗
DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line. Which strategy stands out? 
Via The Motley Fool
News headline image
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
From Insulet Corporation
Via Business Wire
News headline image
3 Reasons We’re Fans of Insulet (PODD)
Shareholders of Insulet would probably like to forget the past six months even happened. The stock dropped 54.4% and now trades at $144.10. This might have i... 
Via StockStory
News headline image
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
From Insulet Corporation
Via Business Wire
What's going on in today's after hours session: S&P500 movers ↗
Via Chartmill
News headline image
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States. 
Via The Motley Fool
Topics Regulatory Compliance
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
Insulet to Participate in William Blair 46th Annual Growth Stock Conference
From Insulet Corporation
Via Business Wire
Which S&P500 stocks are moving on Wednesday? ↗
Via Chartmill
Insulet Corp (NASDAQ:PODD) Blows Past Q1 Estimates, Raises Full-Year Revenue Guidance ↗
Via Chartmill
INSULET CORP (NASDAQ:PODD): A Textbook GARP Candidate for Affordable Growth Investors ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets
From Insulet Corporation
Via Business Wire
News headline image
1 Oversold Stock Set for a Comeback and 2 That Underwhelm
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet... 
Via StockStory
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
The 5 Most Interesting Analyst Questions From Insulet’s Q1 Earnings Call
Insulet’s first quarter was marked by robust revenue growth, driven by continued adoption of its Omnipod 5 insulin delivery system across both U.S. and inter... 
Via StockStory
Topics Earnings
News headline image
Why Insulet (PODD) Stock Is Trading Up Today
What Happened? Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 3.4% in the afternoon session after Benchmark initiated coverage o... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Quality Compounders to Research Further
Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more pr... 
Via StockStory
Which S&P500 stocks are moving on Thursday? ↗
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Which S&P500 stocks have an unusual volume on Wednesday? ↗
Via Chartmill
News headline image
Insulet (PODD) Q1 2026 Earnings Transcript ↗
Insulet (PODD) Q1 2026 Earnings Transcript 
Via The Motley Fool
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Insulet (NASDAQ:PODD) Reports Upbeat Q1 CY2026, Stock Soars
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 33.9% year on... 
Via StockStory
News headline image
Insulet Reports First Quarter 2026 Results
From Insulet Corporation
Via Business Wire
News headline image
Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities
From Insulet Corporation
Via Business Wire
News headline image
Earnings To Watch: Insulet (PODD) Reports Q1 Results Tomorrow
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what investors should know. Insulet beat... 
Via StockStory
News headline image
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
From Insulet Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.